News Releases from Headquarters›Chemical Safety and Pollution Prevention (OCSPP)
EPA Approves Emergency Exemption for Antiviral Air Treatment
WASHINGTON (January 15, 2021) — Today, the U.S. Environmental Protection Agency (EPA) announced approval of an emergency exemption request for use of Grignard Pure, as an additional tool in limited use situations to aid in the fight against COVID-19.
EPA is issuing an emergency exemption for Grignard Pure to be used in certain indoor spaces where social distancing can be challenging. Use of this product does not eliminate the need for critical precautions like mask wearing, social distancing, and ventilation. Always follow CDC, state and local public health guidelines.
This exemption has been granted to Georgia and Tennessee state governments. After carefully reviewing safety and efficacy data, EPA has determined the product will provide another tool to assist States with approved emergency exemptions during the current public health emergency. EPA’s approval will allow the product to be applied in Georgia and Tennessee in certain indoor spaces where adherence to current public health guidelines is impractical or difficult to maintain. Areas of particular concern include breakrooms, locker rooms, bathrooms, lobbies, elevators, eating areas, and food preparation areas within health care facilities, intrastate transportation, food processing facilities, and indoor spaces within buildings—including government facilities—where people are conducting activity deemed essential by the state.
“Today, we are approving the first-ever airborne antiviral product that will help fight the spread of the novel coronavirus that causes COVID-19,” said EPA Administrator Andrew Wheeler. “There is no higher priority for EPA than protecting the health and safety of Americans and I want to thank those—both within EPA and those outside—who have worked to achieve this important milestone.”
“We are deeply grateful to the diligent teams at EPA who were tireless in evaluating and validating the health, safety and efficacy of Grignard Pure as the first-of-its-kind antimicrobial air treatment,” said Etienne Grignard, co-founder and CEO, Grignard Pure. “Grignard Pure is a passion and a mission for us. Since the beginning of the pandemic, we have been singularly focused on making Grignard Pure a critical component in achieving the shared commitment we all have—helping people feel safer, getting industries and our economy back to full operation, and using science, technology and engineering to find solutions that move us past the ravages of COVID-19.”
EPA is approving these emergency exemption requests from Georgia and Tennessee under Section 18 of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA).
Application levels are monitored through visual assessment, or sensors which automatically regulate the amount of product suspended in the air. Additionally, the EPA-approved label requires that signs be posted at every entrance to the spaces notifying the public that the space has been treated.
Triethylene glycol (TEG) is the active ingredient in Grignard Pure. TEG is commonly used in fog machines for concerts and theatre productions. EPA reviewed all available data on this product’s effectiveness and safety and concluded that it is capable of killing 98 percent of airborne SARS-CoV-2. TEG may be an irritant for sensitive populations.
For more information, please visit: https://19january2021snapshot.epa.gov/pesticide-registration/section-18-emergency-exemption-requests-and-coronavirus-covid-19.